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Melatonin is a potent modulator of antioxidative defense and cellular proliferation
against aluminum toxicity in rats
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Abstract: Aluminum is the most abundant metal on earth, known for its toxicity to humans and laboratory animals. Melatonin, produced
by the pineal gland, has been shown to be an effective antioxidant. In this study, we investigated the possible protective role of melatonin
in modulating toxicity and oxidative stress induced by chronic exposure to aluminum in the small intestine of rats. Wistar albino rats
were divided into five groups. Group I served as the control and received only physiological saline, Group II served as the control for
the melatonin group and received ethanol and physiological saline, Group III received melatonin, Group IV received aluminum sulfate,
and Group V received aluminum sulfate and melatonin, injected three times per week for 1 month. Administration of aluminum
caused degenerative changes in small intestine tissues, such as histological damage, increase in metallothionein immunoreactivity,
and decrease in cellular proliferation index. Moreover, intestinal glutathione levels, and catalase, superoxide dismutase, glutathione
peroxidase, sodium/potassium-ATPase, and glucose-6-phosphate dehydrogenase activities decreased, while lipid peroxidation and
myeloperoxidase levels, and alkaline phosphatase, lactate dehydrogenase, and xanthine oxidase activities increased in the aluminum
group. Administration of melatonin mostly prevented these effects. Consequently, we can say that melatonin protects the intestine from
aluminum toxicity through its antioxidant and proliferative effects.
Key words: Aluminum, Melatonin, Metallothionein, Oxidative stress, Rat, Small intestine, Cell proliferation

1. Introduction
Aluminum (Al) is a ubiquitous metal on earth. Al and its
salts are commonly used in various daily applications, such
as water treatment, wood preservation, food additives,
toothpastes, antiperspirants, shampoos, vitamins,
medications, vaccines, antacids, phosphate binders,
buffered aspirin products, packaging materials, or as fillers
in plastics (Yokel and McNamara, 2001; Becaria et al.,
2002; Nayak, 2002; Yenigül, 2006). In the literature, Al has
been shown to have a toxic effect on several tissues and
organs such as the brain, liver, kidneys, testicles, stomach,
parathyroid gland, intestines, and blood tissue (Albendea
et al., 2007; Krewski et al., 2007; Turgut et al., 2007; Amer,
2008; Bogdanovic et al., 2008; Abdel Moneim et al., 2013).
In particular, aluminum sulfate (Al2(SO4)3) has been shown
to cause toxicity to the liver, kidneys, and nervous system
in laboratory animals (Material Safety Data Sheet LA1407
Al2(SO4)3; Schetinger et al., 1999; Gawish, 2005). Although
there are a number of studies investigating Al toxicity,
mechanisms of the damage caused by Al have yet to be
explained. Al-induced toxicity may be due to the increase
in oxidative stress. Zatta et al. (2002) suggested that lipid
* Correspondence: bulan@istanbul.edu.tr

peroxidation (LPO) resulting from oxidative damage is the
mediator of Al toxicity. Together with increasing LPO in
tissues, Al disturbs the antioxidant defense system (AOS).
High levels of reactive oxygen radical (ROS) production
are partially dependent on the presence of low levels of
AOS (Jones, 2008).
Antioxidants show a blocking effect against the
peroxidation chain reaction caused by free radicals.
Melatonin (Mel; N-acetyl-5-methoxytryptamine) is a
powerful antioxidant secreted from the pineal gland
and is capable of reducing free radicals. In addition,
Mel can increase antioxidant enzymatic activity and
secretion. Antioxidant and detoxification enzymes such
as glutathione peroxidase (GSH-Px) and superoxide
dismutase (SOD) play important roles against ROS in
tissues (Ichikawa et al., 1994). Several studies have shown
that Mel has a protective role against tissue damage (Merle
et al., 2000; Reiter et al., 2003; Farías et al., 2012).
Crohn’s disease, which is defined as the thickening of
one or more regions in the mouth, esophagus, stomach,
small intestine, and large intestine, is observed a lot in the
small intestine (Lerner, 2007). Crohn’s disease is defined
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to be an immunological disorder caused by genetic,
microbic, and environmental factors (Çokuğraş, 2011).
There are hypotheses showing that the damage caused by
aluminum in the gastrointestinal tract might be related to
Crohn’s disease (Perl et al., 2004; Sartor, 2006).
The immunoreactivity of metallothionein (MT),
which has a high binding affinity for heavy metals, was
investigated (Cobbet and Goldsbrough, 2002; Al Kahtani,
2010). MT levels are increased in the presence of heavy
metals such as cadmium, mercury, aluminum, zinc,
platinum, and silver or other stress conditions (Carpene et
al., 2007). Additionally, nuclear antigen, which detects cells
in the synthesis phase (Ki-67), was analyzed in order to
determine proliferative activity by immunohistochemistry
(Aguilar-Nascimento, 2006).
In our study, we aimed to determine, with an in vivo
experimental model, whether Al causes damage in the
small intestine, whether Al causes an inflammatory
disorder, and whether Mel has a protective role against
these damages.
2. Materials and methods
2.1. Experimental design and treatment of animals
In our study, male Wistar albino rats (n = 40) weighing
230–250 g from the Experimental Medical Research
Institute (DETAE) of İstanbul University were used. The
experimental protocols were reviewed and approved by the
Animal Care and Use Committee of İstanbul University
(Ethical committee: 102/27.08.2009). The animals were
fed laboratory pellet chow and water ad libitum. All rats
were clinically healthy. The animals were randomly divided
into five groups (n = 8 per group): Group I: control animals
injected intraperitoneally with physiological saline; group
II: Mel control animals injected subcutaneously with
physiological saline containing 2% ethanol (Mel dissolved
in 2% ethanol); group III: animals injected subcutaneously
with 10 mg/kg Mel; group IV: rats injected intraperitoneally
with 5 mg/kg [Al2(SO4)3]; group V: animals receiving
5 mg/kg Al2(SO4)3 intraperitoneally and 10 mg/kg Mel
subcutaneously (Esparza et al., 2003; Salido et al., 2013).
All chemicals were purchased from Sigma-Aldrich (St.
Louis, MO, USA). At the end of the experimental period,
small intestine tissues were obtained from the animals,
which were sacrificed under anesthesia with ketamine
hydrochloride (Ketalar, Pfizer, İstanbul, Turkey).
2.2. Histological study
Intestinal samples taken from the animals were fixed in
Bouin’s fixative, dehydrated with alcohol, and embedded
in paraffin. Sections 5 µm thick were stained with Masson’s
trichrome technique and PAS reaction before being
examined using an Olympus CX41 microscope fitted with
an Olympus DP71 digital camera for recording images. The
semiquantitative histological assessment of small intestine
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damage was done using modified histological criteria
described by Fernandez et al. (2001). These criteria were
as follows: inflammatory cellular infiltration, degeneration
in the epithelia, villus loss and disruption in integrity of
villi hyperemia, disruption of brush border and surface
enterocytes, increase in the number of cells yielding a
dark cytoplasmic reaction, hyperplasia, vacuolization in
epithelial cells, edema in the lamina propria of the villi,
disruption in integrity of the crypts, and necrotic areas in
the mucosa. Each histological variable was scored from
0 (normal) to 3 (maximal damage) to give a maximum
possible score of 24 for each small intestinal sample.
2.3. Immunohistochemical study
Samples from the intestine were fixed in 10% phosphatebuffered formalin. Immunolocalization techniques for MT
and Ki-67 were performed using the streptavidin–biotin–
peroxidase method. Following dewaxing and rehydration of
paraffin-embedded sections, to facilitate antigen retrieval,
sections were rendered permeable with 0.3% Triton X-100
for 10 min and were then heated for 20 min in a microwave
oven (700 W) with 10 mM citrate buffer (pH 6.0).
Endogenous peroxidase activity was blocked by incubating
in Peroxo-Block Solution (Invitrogen, Carlsbad, CA, USA,
Cat. No: 00-2015) for 10 min. The labeling procedure was
performed using the Histostain Plus Broad Spectrum Kit
(Invitrogen, Cat. No: 85-9043). Detection procedures
were carried out in accordance with the manufacturer’s
instructions. Slides were incubated by the application
of mouse antimetallothionein (1:50 in 3% Triton X-100,
Invitrogen, Cat. No: 730693A) and the application of mouse
anti-Ki-67 (1:25 in PBS, Millipore, Billerica, MA, USA, Cat.
No: AB9260) for 60 min at room temperature. Peroxidase
activity of the tissue was demonstrated by AEC (3-amino9-ethylcarbazole, Invitrogen, Cat. No: 00-2007) and then
sections were counterstained with Mayer’s hematoxylin
(Invitrogen, Cat. No: 00-8001). Semiquantitative MTpositive cells and Ki-67-positive cells were detected using
a light microscope (Olympus CX41, Tokyo, Japan). MTpositive cells and Ki-67-positive cells were counted in ten
randomly selected areas from every section (values were
presented as the percentage of total).
2.4. Biochemical study
Small intestine samples were analyzed for biochemical
studies. Tissue samples from small intestine were washed
with physiological saline and stored at –86 °C before
the experiments. As recommended for the ELISA kit,
for myeloperoxidase (MPO) (Hycult, HK-105) and
total glutathione (GSH) (Enzo Lab., 900-160) assays,
homogenization was performed in the small intestinal
tissues. By applying ELISA to the clear supernatants
obtained from the homogenates, MPO and GSH levels were
determined via an ELISA reader (BioTek µQuant, MQX200,
USA) at 450 nm and 405 nm wavelength, respectively.
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Small intestine tissues were homogenized in cold saline
using a glass homogenizer to produce a 10% (w/v)
homogenate for spectrophotometric analyses (Shimadzu
UV-1800, Kyoto, Japan). These homogenates were
centrifuged at 10,000 × g for 10 min and supernatants were
used to determine LPO and total protein levels as well as
for enzymatic analyses.
2.4.1. Determination of LPO
The small intestine tissues’ LPO levels, indicated
by thiobarbituric acid reactive substances (TBARS)
concentration, were measured spectrophotometrically
at 532 nm according to the method developed by
Ledwozyw et al. (1986). Results were defined as nmoles of
malondialdehyde (MDA) per milligram of protein.
2.4.2. Determination of ALP activity
The specific activities of ALP were determined by the
method developed by Walter and Schult (1974). ALP is the
enzyme that catalyzes the hydrolyzation of 4-nitrophenyl
phosphate to 4-nitrophenol due to the pH of the reaction
medium. Under optimum conditions for measurements of
the ALP, the absorbance was monitored at 405 nm. Enzyme
activities were expressed as units per gram of protein.
2.4.3. Determination of CAT activity
CAT activity of the small intestine tissue was determined by
the method described by Aebi (1984). The method is based
on the hydrolyzation of H2O2 into H2O by the effect of CAT
in the reaction mixture, recorded by decrease in absorbance
at 240 nm. One unit of enzyme activity was defined as the
amount of the enzyme per milligram of protein.
2.4.4. Determination of SOD activity
SOD activity was assayed according to the method described
by Mylroie et al. (1986). The reaction mixture contains
potassium phosphate buffer (pH 7.8), o-dianisidine
dihydrochloride, and riboflavin. The reaction was initiated
by addition of riboflavin to the reaction mixture and the
absorbance of the mixture was monitored immediately at
a wavelength of 460 nm and the results expressed as the
enzyme units per gram of protein.
2.4.5. Determination of GSH-Px activity
GSH-Px is an enzyme that catalyzes the conversion of
H2O2 into H2O in the presence of glutathione disulfide
(GSSG) and reduced nicotinamide adenine dinucleotide
phosphate (NADPH). GSSG is reduced to GSH by
utilization of NADPH using glutathione reductase. The
oxidation of NADPH to NADP+ is associated with the
decrease in absorbance at 340 nm. GSH-Px activities were
determined using the method of Mylroie et al. (1986) and
the method described by Paglia and Valentine (1967) and
modified by Wendel (1981). One unit of enzyme activity
was defined as the amount of enzyme per gram of protein.
2.4.6. Determination of LDH activity
Lactate dehydrogenase (LDH) levels were assayed by the
method of Wroblewski (1957). This method is based on

the ability of LDH to convert pyruvate to lactate with
the help of the coenzyme reduced nicotinamide adenine
dinucleotide (NADH). The absorbance of the samples was
measured spectrophotometrically at 340 nm.
2.4.7. Determination of Na+/K+-ATPase activity
Na+/K+-ATPase in the small intestine tissue homogenates
was determined by the method developed by Ridderstap
and Bonting (1969). The main principle of this method
was based on determination of inorganic phosphate (Pi)
after the hydrolyzation of ATP when the homogenate was
incubated with the appropriate amount of ATP. Firstly,
total ATPase activity was assayed and then Mg2+-ATPase
activity was determined in the presence of ouabain. The
Na+/K+-ATPase activity was calculated by subtraction
from total ATPase of Mg2+-ATPase. Results were
expressed as micromoles of Pi per milligram of protein
per hour. The absorbance of the samples was measured
spectrophotometrically at 680 nm.
2.4.8. Determination of G6PD activity
G6PD, the first and the rate-limiting enzyme of the pentose
phosphate pathway, is involved in the antioxidant defense
system in the cell because it is responsible for the production
of NADP. In the small intestine tissue homogenates, G6PD
activity was estimated spectrophotometrically at 340 nm
by the method described by Betke et al. (1967) at 37 °C.
One unit (U) of enzyme activity is the amount of enzyme
required to reduce 1 µmol of NADP+ per minute.
2.4.9. Determination of XO activity
XO activity was evaluated as uric acid production according
to Corte and Stirpe (1968). Briefly, phosphate buffered
solution (PBS) containing ethylenediaminetetraacetic acid
(EDTA) and xanthine was added to each sample and the
solution was incubated for 10 min at 24 °C. The conversion
of xanthine to uric acid caused an increase in absorbance
at 286 nm and one unit of enzyme activity corresponds to
the formation of uric acid per gram of protein.
2.4.10. Determination of proteins
The method of Lowry et al. (1951) was used to determine
total protein levels in the homogenates. Briefly, proteins
were reacted with copper ions in alkaline medium and
reduced by Folin reactive. The absorbance of the blue
colored product was evaluated at 500 nm. Bovine serum
albumin was used as a standard and total protein levels of
tissue were used to express the results of the parameters
per protein.
2.5. Statistical analysis
Histological and immunohistological data were evaluated
statistically using SPSS 15.0 (SPSS, IBM, Chicago, IL,
USA). Data of histological damage score, MT, and Ki-67
immunohistochemistry were analyzed by nonparametric
Kruskal–Wallis test and Mann–Whitney U test.
Biochemical test results were evaluated using one-way
ANOVA and unpaired Student’s t-test using the NCSS
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statistical computer package (NCSS 2001, Kaysville, UT,
USA). Significant differences were considered when P
< 0.05. Histological and immunohistological data were
expressed as mean ± standard error (SE); biochemical data
were expressed as mean ± standard deviation (SD).

3. Results
3.1. Histological results
Light microscopic analysis of small intestine tissue for all
experimental groups is presented in Figure 1. A normal
histological appearance was observed in groups I and II

➤

Figure 1. (A) Histological appearance of the jejunum in a control rat, (v) villus, (c) crypt, Masson’s trichrome, Bar: 200 µm. (B)
Intensive PAS-positive reaction in the brush border of the villi (➞) and in the goblet cells (u) Periodic acid Schiff, Bar: 100 µm.
(C) Histological appearance of the small intestine of aluminum-administered group, inflammatory cellular infiltration in the
lamina propria of the villi (ê), cell yielding dark and narrow cytoplasmic reaction (➡), Masson’s trichrome, Bar: 100 µm. (D)
Disintegration of the epithelium, disruption in the integrity of the villi and villus loss, discontinuity in the brush border of the
villi ( ), cells yielding dark and narrow cytoplasmic reaction (➡), edema in the lamina propriada of the villi (✸), hyperplasia
(h). Masson’s trichrome, Bar: 100 µm. (E) Disruption in the integrity of the crypts and necrotic areas in the mucosa (➨), Masson’s
trichrome, Bar: 100 µm. (F) Decrease in the PAS reaction intensity in the brush border of the villi (➞) and in the goblet cells (u)
Periodic acid Schiff, Bar: 100 µm. (G). Histological appearance of the jejunum of a rat in the melatonin group, Masson’s trichrome,
Bar: 100 µm. (H) The view of the villi in the aluminum+melatonin group, Masson’s trichrome, Bar: 100 µm. (I) Increase in the PAS
reaction intensity in the brush border of the villi (➞) and in the goblet cells (u) Periodic acid Schiff, Bar: 100 µm.
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3.2. Immunohistochemical results
Immunoreactive MT-producing cells were observed in the
small intestine (Figure 3). Semiquantitative assessment
of MT immunoreactivity in crypt epithelial cells was
conducted (Figure 4). With respect to the control group,
the number of MT-positive cells in the Al and Al+Mel
groups increased significantly (P < 0.001). In addition, the
% MT-positive crypt cell significantly increased in Al+Mel
group compared to the melatonin control group (P < 0.05),
but it notably decreased in the Al group (P < 0.001). In
the Mel-only group, there was a significant increase when
compared to the Mel control group (P < 0.05).
Proliferation index was determined using Ki-67
immunohistochemistry in crypt epithelial cells (Figure 5).
Semiquantitative assessment of Ki-67 immunoreactivity
showed a pronounced decrease in the Al-injected group
(P < 0.05). In the Al+Mel group, the number of Ki-67positive cells was significantly higher than that in the
Al group (P < 0.05). However, in this group there was a
significant decrease according to the control group (P <
0.05), Mel control group (P < 0.05), and Mel-only group (P
< 0.05) (Figure 6).
3.3. Biochemical results
MPO and GSH values of the homogenates of the small
intestine are given in Table 1. While the MPO values of the
Al group increased in a statistically meaningful manner
(P < 0.01), the Al+Mel group showed a nonsignificant
decrease when compared to the Al group. GSH levels
in the group given Al insignificantly decreased when
compared to the control group. However, GSH levels of
the Al+Mel group significantly increased compared with

Histological damage score

(Figure 1A). In the control groups, goblet cells’ mucous
secretion and lined contours of absorptive cells gave an
intensive PAS reaction (Figure 1B). When cross sections
of the Al group were compared with those of the control
individuals, significant damage was observed (Figures
1C–1E).
The significant findings in this group were inflammatory
cellular infiltration, disintegration in the epithelia, disorder
and loss in the integrity of villi, hyperemia, discontinuity
in the lined contours, increase in the cellular count of
cells yielding dark and narrow cytoplasmic reactions,
hyperplasia, vacuolization of the epithelial cells, edema
in the lamina propria of villi, disorder in the integrity
of the gland, and necrotic areas in the mucosae. It was
determined that the intensity of the PAS reaction observed
in the goblet cells was decreased when compared to the
control group (Figure 1F).
In the Mel group, histological observations were
similar to those in the control group (Figure 1G). In
the Al+Mel group, a significant decrease was observed
compared to the Al group (Figure 1H). The PAS-positive
reaction intensity of the cross sections, and in the lined
contours of the epithelial cells and goblet cells in this group
increased compared to the aluminum group (Figure 1I).
When compared to the control individuals, the increases
in histologic damage score of the Al and Al+Mel groups
were statistically meaningful (P < 0.01). The damage score
of Al+Mel group [while it was increasing in a statistically
meaningful manner where melatonin control (P < 0.01)
and melatonin groups (P < 0.05) were concerned] showed
a significant decrease compared to the Al group (P < 0.001)
(Figure 2).

Figure 2. Histological damage score of the small intestine. The values obtained for each group were presented as mean ± standard error
(SE). Control (n = 6): 4.83 ± 0.6, Melatonin control (n = 6): 4.02 ± 0.96, Melatonin (n = 6): 5.03 ± 1.09, Aluminum (n = 8): 18.12 ± 0.85,
Aluminum+melatonin (n = 7): 8.57 ± 0.68.
a
Different than the control group (P < 0.01); b Different than the Mel control group (P < 0.01)
c
d
Different than the Mel group (P < 0.05);
Different than the Al group (P < 0.001)
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Figure 3. MT-positive epithelial cells in the crypts (➜). (A) Control group, (B) Aluminum group, (C) Aluminum+melatonin group.

Figure 4. Percent MT-positive cellular count determined using MT immunohistochemistry in the crypt epithelial cells. The values
obtained for each group were presented as ‘mean ± SE’. Control (n = 8): 3.19 ± 0.17, Melatonin control (n = 8): 4.08 ± 0.21, Melatonin
(n = 7): 4.55 ± 0.11, Aluminum (n = 8): 13.16 ± 0.94, Aluminum+melatonin (n = 7): 5.34 ± 0.4.
a
Different than the control group (P < 0.001); b Different than the Mel control group (P < 0.05); c Different than the Al group (P < 0.001)

Figure 5. Ki-67-positive epithelial cells in the intestinal mucosa (➜) (A) Control group, (B) Aluminum group, (C) Aluminum+melatonin
group.
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Figure 6. The percentage of Ki-67-positive cells determined by Ki-67 immunohistochemistry of the crypt epithelial cells. The values
obtained for each group were presented as ‘mean ± SE’. Control (n = 3): 96.49 ± 0.28, Melatonin control (n = 3): 97.27 ± 0.12, Melatonin
(n = 4): 96.56 ± 0.20, Aluminum (n = 4): 93.22 ± 0.17, Aluminum+melatonin (n = 4): 95.13 ± 0.41.
a
b
Different than the control group (P < 0.05);
Different than the Mel control group (P < 0.05)				
c
d
Different than the Mel group (P < 0.05);
Different than the Al group (P < 0.05)

the Mel control (P < 0.01), only Mel (P < 0.05), and only Al
(P < 0.01) groups (Table 1).
LPO levels and the activities of ALP, CAT, SOD, and
GSH-Px are presented in Table 2. The level of LPO in
the small intestine tissue was significantly increased in
the Al group compared to the control group (P < 0.005).
Administration of Mel significantly decreased the level
of LPO in the Al group (P < 0.05). ALP activity in the
Al group was significantly increased when compared to
the control group (P < 0.005). However, Mel treatment
significantly decreased ALP activity in the Al group (P <
0.05). CAT, SOD, and GSH-Px activities were significantly
decreased in the group given Al when compared to
the control group (P < 0.005; P < 0.05). Mel treatment
markedly increased intestinal CAT, SOD, and GSH-Px

activities in Al administered animals (P < 0.05, P < 0.005)
(Table 2).
The small intestine LDH, Na+/K+ATPase, G6PD,
and XO activities are given in Table 3. LDH and XO
activities in the group given Al significantly increased
when compared to the control group (P < 0.05; P < 0.005).
However, Mel treatment significantly decreased LDH and
XO activities in Al administered rats (P < 0.005). G6PD
activity was insignificantly increased in the Al group.
However, G6PD activity was insignificantly decreased
with the administration of Mel. Na+/K+-ATPase activity
in intestinal tissue was significantly decreased in the Al
administered group (P < 0.05). On the other hand, Mel
treatment caused a significant increase in the Na+/K+ATPase activity in the rats given Al (P < 0.05) (Table 3).

Table 1. Small intestine GSH and MPO levels in control and experimental groups.
Groups

GSH
(nmol/mg protein)*

MPO
(ng/mg protein)*

Control

5.40 ± 0.84

28.69 ± 4.32

Melatonin control

3.49 ± 0.65

34.96 ± 6.38

Melatonin

4.41 ± 0.44

46.09 ± 6.26

Aluminum

3.31 ± 0.21

80.53 ± 11.18a

Aluminum+melatonin

9.12 ± 1.45b,c,d

50.88 ± 12.24

Mean ± SD
P < 0.01 compared with the control group.		
b
P < 0.01 compared with the Mel control group.
c
P < 0.05 compared with the Mel group.
d
P < 0.01 compared with the aluminum group.
*

a
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Table 2. Small intestine LPO, ALP, CAT, SOD, and GSH-Px activities in control and experimental groups.
Groups

LPO
(nmol MDA/mg protein)*

ALP
(U/mg protein)*

CAT
(U/mg protein)*

SOD
(U/mg protein)*

GSH-Px
(U/g protein)*

Control

0.69 ± 0.29

12.40 ± 5.44

7.77 ± 1.82

6.85 ± 2.28

36.6 ± 8.21

Melatonin+control

0.92 ± 0.39

15.05 ± 3.70

3.45 ± 2.06

6.03 ± 1.91

31.67 ± 28.27

Melatonin

1.13 ± 0.30

17.70 ± 6.77

5.24 ± 1.90

5.37 ± 3.04

41.47 ± 36.02

Aluminum

1.58 ± 0.34a

21.31 ± 4.46a

3.94 ± 0.73a

3.49 ± 1.71d

22.10 ± 6.63d

Aluminum+melatonin

0.92 ± 0.14b

15.33 ± 3.98b

10.12 ± 2.81c

9.54 ± 3.18b

38.53 ± 10.40b

Mean ± SD
P < 0.005 compared with the control group. 			
c
P < 0.005 compared with the aluminum group.			

*

a

b

P < 0.05 compared with the aluminum group. 			
P < 0.05 compared with the control group.

d

Table 3. Small intestine LDH, Na+/K+-ATPase, G6PD, and XO activities in control and experimental groups.
Groups

LDH
(U/mg protein)*

Na+/K+-ATPase
(µmol Pi/mg protein)*

G6PD
(U/g protein)*

XO
(U/mg protein)*

Control

12.83 ± 3.73

0.95 ± 0.27

3.38 ± 1.59

0.21 ± 0.09

6.59 ± 3.16

0.79 ± 0.35

3.31 ± 2.09

0.31 ± 0.07

Melatonin

11.10 ± 5.23

0.32 ± 0.18

1.53 ± 1.78

0.57 ± 0.13

Aluminum

25.76 ± 8.78a

0.41 ± 0.11a

8.08 ± 7.74

1.04 ± 0.19d

Aluminum+melatonin

9.97 ± 4.71b

1.78 ± 1.02c

5.67 ± 3.60

0.25 ± 0.13b

Melatonin control

Mean ± SD
P < 0.05 compared with the control group.		
b
P < 0.005 compared with the aluminum group.		
c
P < 0.05 compared with the aluminum group.		
d
P < 0.005 compared with the control group.

*

a

4. Discussion
Al is broadly used in daily life throughout the world. Al
has toxic effects in all living organisms including plants
(Ganrot, 1986). Owing to its negative effects on human
health, Al has become a highly researched metal (ElMaraghy et al., 2001; Mahmoud and Elsoadaa, 2013). Mel
is a small molecule, well documented as an antioxidant
in numerous toxicological models of induced oxidative
damage (Li et al., 2008). The small intestine plays an
important role in the detoxification of various substances
toxic to the body, as well as in the absorption of foods
(Kierszenbaum, 2006). Aluminum sulfate, which is
the preferred form of aluminum salt in our study, was
selected due to the fact that it is the most absorbed
form of Al salt by the small intestine, as determined by
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Cunat et al. (2000). El-Maraghy et al. (2001) found that,
after injecting aluminum salt into rats, there was a 35%
increase in the Al level of hepatic tissue, whereas serum
Al levels contained 209% more Al than the normal values.
Khattab (2007) observed histological damage and loss of
tissue in the testicles after injecting aluminum sulfate into
rats. Güçlü and Serin (2004) investigated inflammations
of the large intestine and observed edema, hyperplasia
in the epithelial cells, hyperemia, increase in the counts
of cells giving dark cytoplasmic reaction, disorder in
the integrity of the gland, and tissue loss. Oktay (2001)
suggested that inflammatory bowel diseases activate the
immune system, which can be understood by infiltrations
into lymphocytes in the lamina propria, and macrophages
and other cells.
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Aslan et al. (2008) concluded that selenium, an
antioxidant element, prevents oxidative damage in
inflammation of the intestine. Another study states that
Wistar albino rats administered with drinking water and
aluminum chloride had edema and tissue disintegration
in their brain, and showed that vitamin E and C given as
antioxidants reduced the damage that occurred (Hussein
et al., 2010). Mel is one of the most powerful antioxidants,
terminating lipid peroxidation, by capturing peroxyl
radicals (Karbownik and Reiter, 2000; Li et al., 2008;
Millan-Plano et al., 2010). Mel shows an antioxidant effect
in the presence of metals causing oxidative stress, thereby
reducing the damage occurring or eliminating it altogether
(Reiter et al., 2003; Sharma et al., 2011). In a study with
mice undergoing ionizing radiation, it was shown that
Mel exhibits a protective effect against tissue damage and
reduces DNA damage to the lowest level (Karbownik and
Reiter, 2000). Vardi et al. (2007) performed a histological
study by applying chronical Mel and showed that in the
damage of rat liver, Mel increases the intensity of the PAS
reaction and notably fixes the damage done to the hepatic
tissue.
In our study, the histological damage findings occurring
in the small intestine due to the effect of aluminum were
in parallel with the damage parameters observed in the
studies mentioned above and showed that inflammation
is present in the tissue. In addition, as stated by Vardi et al.
(2007), we also determined that the PAS-positive reaction
intensity was increased in the Al+Mel group, whereas
it was decreased in the Al group, goblet cells, and lined
contours. It is well known that the PAS reaction is an
indicator of the presence of tissue carbohydrates (Bancroft
and Stevens, 1982). Changes in the structures and amounts
of PAS-positive substances may change the intensity of
the color (Dahlquist et al., 1965). The probable causes of
the decrease in the PAS (+) reaction are the decrease or
disintegration in their chemical structure in the building
blocks constituted of the materials forming the cellular
envelope and mucous materials in goblet cells. Based on
previous studies, melatonin was used as an antioxidant in
the Al+Mel-administered group, preventing the formation
of oxidative stress and mostly preventing histological
damage findings in the aluminum group.
Malekshah et al. (2005) showed that pregnant mice
receiving intraperitoneal injection of Al developed
abnormalities in the fetus and there was a reduction in
the body weight of the mother. As a result, it has been
concluded that Al causes reductions in the syntheses
of DNA and RNA, and prevents embryonic cellular
proliferation and protein synthesis.
Ki-67 is a marker of cellular proliferation and a nuclear
antigen produced during cell division. Therefore, this
feature of Ki-67 is used to determine the cells undergoing

mitosis (Aguilar-Nascimento, 2006). In order to observe
the effect of Al on cellular proliferation, we performed
Ki-67 immunohistochemistry and it revealed that, in
conformity with the studies mentioned above, Al groups
showed less marked crypt cellular counts than the control
groups, whereas in the presence of Mel, marking rate
increased. Al causes reductions in cellular proliferation
by blocking DNA, RNA, and protein synthesis, whereas
Mel increases proliferation via its antioxidant property.
MT has an important role in preventing metal toxification
and showing an intracellular effect against oxidative stress
owing to its high binding capacity (Nordberg, 1998). MT
can bind to physiologic metals like copper and zinc, as well
as heavy metals like cadmium, silver, and aluminum.
In many studies, MT is used to show the presence
of heavy metals in cells and tissues (Zhou et al., 2006;
Amaral et al., 2007). Those authors showed that orally
administered aluminum in rats increased the MT ratio in
the small intestine. In our study, based on these findings,
MT-positive cell counts were increased in the aluminum
group, while in the presence of melatonin, the counts were
reduced. The increase in MT-positive cell count in the
Al group was considered to arise from the role of MT in
preventing toxicity and oxidative stress due to aluminum
in the small intestine. At the same time, this increase shows
the accumulation of Al in the small intestine with the
applied dose of aluminum sulfate. In the Al+Mel group,
the reduction in MT-positive cell count can be speculated
to be the result of the reduction in toxicity and oxidative
stress in the presence of melatonin.
Lipid peroxidation is a basic event involved in various
diseases. Increased ROS were reported during Al exposure
(Exley, 2004). ROS attack almost all the cellular components
including membrane lipids via lipid peroxidation. It is
commonly accepted that the propagation of the radical
reaction in lipid bilayers is disturbed by the rapid diffusion
of peroxyl radicals (Garrec et al., 2014). Al can directly
interact with protective enzymes like SOD, GSH-Px, and
CAT in the living tissues. As a result of this interaction,
free radicals are generated (Mercan, 2004). When the
number of ROS is increased, they start to create damage
by interacting with the other ions present. To prevent this,
intracellular antioxidant defense systems are developed
(Andreyev et al., 2005).
GSH is a very important antioxidant taking part in
the synthesis of DNA, fixing damaged parts of DNA,
inactivating toxic substances, and preventing the possible
damage of free radicals (Chavan et al., 2005).
In reduced form, GSH is necessary for the
detoxification of xenobiotics. In the current study, GSH
levels were decreased, indicating that Al-induced damage
was associated with oxidative stress. This decrease in
GSH levels could be due to the exhaustion of GSH
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reserves and the increase in oxidative stress. Esparza et
al. (2003) suggested increased generation of free radicals
and oxidative stress in the toxic mechanism of Al. Here,
GSH levels were depleted, indicating that Al-induced
histoid damage was associated with oxidative stress. Mel
administration produced an increase in the GSH levels in
small intestine tissue.
Inflammation is a reaction of the living tissues to
damage, a protective response. MPO secreted from the
neutrophils, activated in response to the pathogenic effects,
catalyzes H2O2 molecules in the medium and produces
hypochlorous acid (HOCl), a powerful oxidant. This
powerful radical, having toxic effects on tissues, continues
to show toxic effect with increasing free radicals in the
medium. Krudeiner and Verspaget (2002) showed that
oxidative stress occurs with the abundance of free radicals
created by leucocytes in the inflammation of intestines,
thereby the damage in the inflammatory region progresses.
In our study, the MPO values were determined, which are
both a measure of inflammation (Loria et al., 2008) and an
indicator of oxidative stress with their prooxidant property
(Honda et al., 2009). The increase in MPO values in the
aluminum group is indicative of the fact that Al might
produce free radicals in the small intestine and, therefore,
cause oxidative stress and inflammation in the tissues. The
edema and inflammatory cellular infiltration, observed
histologically in the Al group, supports this finding. MPO
values in our study suggest that the toxic effect occurring
in the intestinal mucosae due to the effect of Al may cause
inflammation. Mel, the antioxidant on the other hand,
when administered with Al, causes a reduction in the MPO
values. Al is accumulated in different organs of dialysis
patients or patients undergoing long-term treatment
with total parenteral nutrition (Alfrey et al., 1976; Klein,
1993). In previous studies, Al treatment has been shown
to increase free radical formation and cell injury due to
oxidative damage in various tissues (Belaid-Novira et al.,
2013; Karabulut-Bulan et al., 2015).
LPO is one of the main manifestations of oxidative
damage. It has been found to play an important role in
the toxicity of many xenobiotics and chemical compounds
(Anane and Creppy, 2001). Our results indicated increased
LPO levels in the small intestine tissue in response to Al
treatments. Mel treatments decreased the increased LPO
levels.
ALP is an important biomarker in medical diagnosis.
Abnormal levels of ALP are closely related to a variety of
pathological process and damage (Milan, 2006). Moreover,
ALP activity has been associated with inflammatory
process and tissue damage (Oktay et al., 2015). In our
study, a significant increase was detected in the ALP
activity of the Al group compared with the control group.
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Mel treatment in the Al group decreased the ALP activity
compared with the Al group. Increased activity of ALP
indicates inflammation and neutrophil activation caused
by Al in small intestine tissue. Akinrinade et al. (2015)
reported increased ALP activity in the brain due to Al
treatment. Sumathi et al. (2015) also found increased ALP
activity in rat brain treated with Al.
Antioxidant enzymes play an important role in the
detoxification of peroxides and radicals in cells. The
primary antioxidant enzymes responsible for protection
against ROS are CAT, SOD, and GSH-Px. Oxidant injury is
recognized as playing a key role in the pathophysiological
pathways in a wide variety of clinical and experimental
diseases (Karabulut-Bulan et al., 2015).
In the present study, Al caused oxidative stress
and consequently reduced the activities of antioxidant
enzymes (CAT, SOD, and GSH-Px). It was indicated that
Al induced oxidative stress by inhibiting the activities of
antioxidant enzymes such as CAT, SOD, and GSH-Px.
These finding are consistent with several other studies that
reported significant decreases in antioxidant enzymes in
tissues (Cheng et al., 2014; Karabulut-Bulan et al., 2015).
After treatment of rats with Al+Mel, the activities of these
antioxidant enzymes were normalized to their control
values. Mel reversed these activities.
Indeed even if LDH increase is a general marker of
cell injury, it could be indicative of tissue damage. In our
study, treatment with Al caused a significant increase in
LDH activity. Anane and Creppy (2001) reported that the
activities of LDH were increased during Al exposure and
this was used as a marker of Al toxicity. Mel could reverse
this process and decrease the activity in the small intestine
of Al-treated rats.
In recent years, Al inhibitory effect on Na+/K+-ATPase
has been observed in several studies (Silva et al., 2005,
2013). Our results showed a decrease in Na+/K+-ATPase
activity in the Al group. Al treatment increased LPO levels.
LPO products inhibited integrated ion transport proteins.
Increasing the value of LPO, Na+/K+-ATPase activity is
associated with a decrease in value. Administration of Mel
reversed these changes. Mel may be used as a free radical
scavenger in the treatment of ROS-related diseases.
G6PD is the first enzyme of the hexose monophosphate
shunt. G6PD reaction is an important site of metabolic
control. This enzyme is required for the antioxidant defense
system, because of its role in the production of NADPH for
the generation of GSH (Change et al., 1979). In our study,
we showed that following the administration of Al, small
intestine G6PD activity increased. Administration of Mel
significantly decreased the G6PD activity in the Al group.
XO activity can produce ROS. In our study, XO activity
increased in the Al group. Administration of Mel decreased
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the activity of XO and ROS. This decrease could be due to
antioxidant properties of Mel. Mel eliminates free radicals
so that intestinal tissue damage can be avoided.
Crohn’s disease damages the intestinal tissue by causing
inflammations in the intestine. Lerner (2007) suggested
that aluminum might play a role in Crohn’s disease.
It is considered that the effect causing inflammation
in Crohn’s disease might be the interaction between
aluminum and bacteria. In another study, free radicals
were suggested to cause the reduction in GSH values
observed in Crohn’s disease (Sido et al., 2006). Kruidenier
et al. (2003) reported that reactive oxygen radicals might
cause damage by disrupting tissue molecules’ structure
in inflammatory diseases such as Crohn’s disease and
inflammatory bowel disease. These researchers measured
CAT, GSH-Px, GSH, and MPO values, the last of these
being an oxidative parameter. In their results, GSH values
decreased compared with the control group, whereas
MPO values increased. Our results were in accordance
with these researchers’ data. We consider that, along with
the inflammatory cellular infiltration we observed in our
histological findings, the hypothesis that aluminum might
cause Crohn’s disease is supported.

Mel and its metabolites not only act as antioxidants
but also have anti-inflammatory effects (Ma et al., 2014).
Mel acts directly to detoxify ROS such as peroxynitrite
anion, singlet oxygen, hydroxy radicals, and reactive
nitrogen species and prevents cell membrane oxidative
stress (Allegra et al., 2003; Reiter et al., 2004). Beneficial
effects of Mel have been extensively presented in various
pathological conditions associated with free radicals and
chronic inflammation, ionizing radiation, mitochondrial
toxin, cerebral ischemia/reperfusion injury, and neuronal
excitotoxicity (Nazıroğlu, 2012; Nazıroğlu et al., 2012;
Reiter et al., 1997, 2003; Ekmekcioglu, 2006). In our study,
microscopic and biochemical results revealed that Mel
protects against Al-induced small intestinal toxicity in rats.
Consequently, we can say that Mel protects the small
intestine against Al toxicity through its antioxidant and
proliferative effects.
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